Ribapharm Names CFO, General Counsel
- Share via
Ribapharm Inc. named William Comer as chief financial officer and Mel Deutsch as general counsel, replacing executives who resigned last month amid a dispute with majority shareholder ICN Pharmaceuticals Inc.
Comer most recently worked as CFO of Premier Practice Management Inc., Ribapharm said. Deutsch had been general counsel at the same company.
Shares of ICN fell 32 cents to $10.84 on the New York Stock Exchange. Ribapharm fell 4 cents to $6.36, also on the NYSE. Both companies are based in Costa Mesa.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
